Coherus Oncology, Inc.

This study is testing whether adding the immunotherapy drug toripalimab to standard chemotherapy works better for people with recurrent or metastatic nasopharyngeal cancer (a type of throat cancer) who haven't had prior treatment for their advanced disease. It will involve about …

This study is testing a new three-drug combination (casdozokitug, toripalimab, and bevacizumab) for people with advanced liver cancer that cannot be removed by surgery. The main goals are to find a safe and effective dose and to see how well the treatment shrinks tumors. It will …

This is the first study in people to test a new drug called CHS-114, which is designed to help the immune system fight cancer. It will be given alone and in combination with another immunotherapy drug to adults with advanced solid tumors, including head and neck cancer, that have…

This is an early-stage study testing the safety and initial effectiveness of a new drug called CHS-114 when combined with an existing immunotherapy (toripalimab) and possibly other standard treatments. It is for adults with advanced or metastatic solid tumors, including specific …